Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Doi, Y."" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 27538
Tytuł:
Doi y Crossref
Autorzy:
Dalila Fragoso Tejas
Pokaż więcej
Temat:
Blog
Botany
QK1-989
Źródło:
Botan‪ical Sciences, Vol 1, Iss 1 (2022)
Opis pliku:
electronic resource
Relacje:
https://www.botanicalsciences.com.mx/index.php/botanicalSciences/article/view/3133; https://doaj.org/toc/2007-4298; https://doaj.org/toc/2007-4476
Dostęp URL:
https://doaj.org/article/2bb0b6fb08e24f96a84c1c918d1aba9e  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii
Autorzy:
Kanchanasuwan S
Kositpantawong N
Singkhamanan K
Hortiwakul T
Charoenmak B
Ozioma F N
Doi Y
Chusri S
Pokaż więcej
Temat:
outcome
cefoperazone-sulbactam
ventilator-associated pneumonia
carbapenem-resistant acinetobacter baumannii
Infectious and parasitic diseases
RC109-216
Źródło:
Infection and Drug Resistance, Vol Volume 14, Pp 1255-1264 (2021)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/outcomes-of-adjunctive-therapy-with-intravenous-cefoperazone-sulbactam-peer-reviewed-article-IDR; https://doaj.org/toc/1178-6973
Dostęp URL:
https://doaj.org/article/742f809644e94879a43b3136961e5998  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Association between urinary uric acid excretion and kidney outcome in patients with CKD.
Autorzy:
Asahina Y; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Sakaguchi Y; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan. .
Oka T; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Hattori K; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Kawaoka T; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Doi Y; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Yamamoto R; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.; Health and Counseling Center, Osaka University, Toyonaka, Japan.
Matsui I; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Mizui M; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Kaimori JY; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Isaka Y; Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 01; Vol. 14 (1), pp. 5119. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Uric Acid*/urine
Renal Insufficiency, Chronic*/urine
Humans ; Retrospective Studies ; Kidney ; Glomerular Filtration Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of Group Exercise Intervention on Quality of Life and Physical Parameters in Patients with Childhood Cancer: A Systematic Review.
Autorzy:
Doi Y; Department of Health Science, Faculty of Medicine, Kobe University, 7-10-2 Tomogaoka, Kobe 654-0142, Japan.
Ogawa M; Department of Rehabilitation, Faculty of Health Sciences, Osaka Health Sciences University, 1-9-27 Temma, Osaka 530-0043, Japan.; Department of Public Health, Graduate School of Health Sciences, Kobe University, 7-10-2 Tomogaoka, Kobe 654-0142, Japan.; Cardiovascular stroke Renal Project (CRP), 7-10-2 Tomogaoka, Kobe 654-0142, Japan.
Ishihara K; Department of Public Health, Graduate School of Health Sciences, Kobe University, 7-10-2 Tomogaoka, Kobe 654-0142, Japan.; Cardiovascular stroke Renal Project (CRP), 7-10-2 Tomogaoka, Kobe 654-0142, Japan.; Department of Physical Therapy, Faculty of Nursing and Rehabilitation, Konan Women's University, 6-2-23 Morikitamachi, Kobe 658-0001, Japan.
Inoue J; Division of Rehabilitation Medicine, Kobe University Hospital International Clinical Cancer Research Center, 1-5-1 Minatojima Minamimachi, Kobe 650-0047, Japan.
Izawa KP; Department of Public Health, Graduate School of Health Sciences, Kobe University, 7-10-2 Tomogaoka, Kobe 654-0142, Japan.; Cardiovascular stroke Renal Project (CRP), 7-10-2 Tomogaoka, Kobe 654-0142, Japan.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 15; Vol. 31 (2), pp. 1035-1046. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Exercise Therapy*
Neoplasms*/therapy
Quality of Life*
Child ; Humans ; Young Adult ; Adolescent
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Trends in Prescribing Antipsychotics for Children and Adolescents in Japan: A Descriptive Epidemiological Study Using a Large-Scale Pharmacy Dataset.
Autorzy:
Nakane S; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Tanaka-Mizuno S; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.; Department of Digital Health and Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan.
Nishiyama C; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.; Department of Critical Care Nursing, Kyoto University Graduate School of Human Health Science, Kyoto, Japan.
Kochi K; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.; Drug Development Division, Sumitomo Dainippon Pharma Co., Ltd, Tokyo, Japan.
Yamamoto-Sasaki M; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Takeuchi M; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Ogawa Y; Department of Healthcare Epidemiology, School of Public Health in the Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Doi Y; Ain Holdings Inc, Sapporo, Hokkaido, Japan.
Arai M; Kraft Inc, Chiyoda, Tokyo, Japan.
Fujii Y; Ain Holdings Inc, Sapporo, Hokkaido, Japan.
Matsunaga T; Kraft Inc, Chiyoda, Tokyo, Japan.
Furukawa TA; Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine and School of Public Health, Kyoto, Japan.
Kawakami K; Department of Pharmacoepidemiology, Kyoto University Graduate School of Medicine and Public Health, Yoshidakonoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan. .
Pokaż więcej
Źródło:
Child psychiatry and human development [Child Psychiatry Hum Dev] 2023 Oct; Vol. 54 (5), pp. 1250-1257. Date of Electronic Publication: 2022 Feb 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antipsychotic Agents*/therapeutic use
Pharmacy*
Male ; Humans ; Child ; Adolescent ; Female ; Japan/epidemiology ; Risperidone/therapeutic use ; Epidemiologic Studies ; Drug Prescriptions
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens – The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study
Autorzy:
Bassetti M
Ariyasu M
Binkowitz B
Nagata TD
Echols RM
Matsunaga Y
Toyoizumi K
Doi Y
Pokaż więcej
Temat:
best available therapy
cefiderocol
carbapenem resistance
pathogen-focused study design
rapid diagnostics
streamlined/limited clinical development
Infectious and parasitic diseases
RC109-216
Źródło:
Infection and Drug Resistance, Vol Volume 12, Pp 3607-3623 (2019)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/designing-a-pathogen-focused-study-to-address-the-high-unmet-medical-n-peer-reviewed-article-IDR; https://doaj.org/toc/1178-6973
Dostęp URL:
https://doaj.org/article/0d5a1e13a1f3448aad81157a1afa39a1  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
La importancia del DOI y el formato HTML en la difusión del conocimiento médico y científico actual. (Spanish)
Autorzy:
RAMÍREZ-RENTERÍA, CLAUDIA
Pokaż więcej
Temat:
DIFFUSION of innovations
MEDICAL informatics
PROGRAMMING languages
Alternatywny tytuł:
The importance of DOI and HTML format in the current diffusion of medical and scientific knowledge. (English)
Źródło:
Revista Mexicana de Endocrinología, Metabolismo y Nutrición; ene-mar2020, Vol. 7 Issue 1, p5-9, 5p
Czasopismo naukowe
Szczegóły
Tytuł:
The Metabolic Regulation of Amino Acid Synthesis Counteracts Reactive Nitrogen Stress via Aspergillus nidulans Cross-Pathway Control.
Autorzy:
Amahisa M; Microbiology Research Center for Sustainability, Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8572, Japan.
Tsukagoshi M; Microbiology Research Center for Sustainability, Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8572, Japan.
Kadooka C; Microbiology Research Center for Sustainability, Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8572, Japan.
Masuo S; Microbiology Research Center for Sustainability, Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8572, Japan.
Takeshita N; Microbiology Research Center for Sustainability, Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8572, Japan.
Doi Y; Microbiology Research Center for Sustainability, Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8572, Japan.
Takagi H; Institute for Research Initiatives, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma 630-0192, Japan.
Takaya N; Microbiology Research Center for Sustainability, Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8572, Japan.
Pokaż więcej
Źródło:
Journal of fungi (Basel, Switzerland) [J Fungi (Basel)] 2024 Jan 10; Vol. 10 (1). Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study.
Autorzy:
Kai M; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Hikita H; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kazuki M; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Tahata Y; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Shinkai K; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Doi A; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Ohkawa K; Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, Osaka, Osaka, Japan.
Miyazaki M; Department of Gastroenterology and Hepatology, Osaka Police Hospital, Osaka, Osaka, Japan.
Ishida H; Department of Gastroenterology and Hepatology, Ikeda Municipal Hospital, Ikeda, Osaka, Japan.
Matsumoto K; Department of Gastroenterology and Hepatology, Toyonaka Municipal Hospital, Toyonaka, Osaka, Japan.
Nozaki Y; Department of Gastroenterology and Hepatology, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan.
Yakushijin T; Department of Gastroenterology and Hepatology, Osaka General Medical Center, Osaka, Osaka, Japan.
Sakamori R; Department of Gastroenterology and Hepatology, National Hospital Organization Osaka National Hospital, Osaka, Osaka, Japan.
Kaneko A; Department of Gastroenterology and Hepatology, Japan Community Healthcare Organization Osaka Hospital, Osaka, Osaka, Japan.
Iio S; Department of Gastroenterology and Hepatology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan.
Nawa T; Department of Gastroenterology and Hepatology, Higashiosaka City Medical Center, Higashiosaka, Osaka, Japan.
Kakita N; Department of Gastroenterology and Hepatology, Kaizuka City Hospital, Kaizuka, Osaka, Japan.
Morishita N; Department of Gastroenterology and Hepatology, Minoh City Hospital, Minoh, Osaka, Japan.
Hiramatsu N; Department of Gastroenterology and Hepatology, Osaka Rosai Hospital, Sakai, Osaka, Japan.
Usui T; Department of Gastroenterology and Hepatology, Ashiya Municipal Hospital, Ashiya, Hyogo, Japan.
Imanaka K; Department of Gastroenterology and Hepatology, Itami City Hospital, Itami, Hyogo, Japan.
Doi Y; Department of Gastroenterology and Hepatology, Otemae Hospital, Osaka, Osaka, Japan.
Sakakibara M; Department of Gastroenterology and Hepatology, Yao Municipal Hospital, Yao, Osaka, Japan.
Yoshida Y; Department of Gastroenterology and Hepatology, Suita Municipal Hospital, Suita, Osaka, Japan.
Oze T; Department of Gastroenterology and Hepatology, Koga Community Hospital, Yaidu, Shizuoka, Japan.
Kodama T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Tatsumi T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Takehara T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 02; Vol. 19 (1), pp. e0294590. Date of Electronic Publication: 2024 Jan 02 (Print Publication: 2024).
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/drug therapy
Humans ; Aged ; Bevacizumab/adverse effects ; Antibodies, Monoclonal, Humanized/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Trace Metal Impurities Effects on the Formation of [ Cu]Cu-ATSM).
Autorzy:
Shinada M; Faculty of Science, Toho University, Funabashi 274-8510, Japan.; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.; Kanagawa Cancer Center, Kanagawa 241-8515, Japan.
Suzuki H; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Hanyu M; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Igarashi C; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.; Kanagawa Cancer Center, Kanagawa 241-8515, Japan.
Matsumoto H; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.; Kanagawa Cancer Center, Kanagawa 241-8515, Japan.
Takahashi M; Faculty of Science, Toho University, Funabashi 274-8510, Japan.; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Hihara F; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Tachibana T; Faculty of Science, Toho University, Funabashi 274-8510, Japan.; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Sogawa C; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Zhang MR; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Higashi T; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Sato H; Kanagawa Cancer Center, Kanagawa 241-8515, Japan.
Kurihara H; Kanagawa Cancer Center, Kanagawa 241-8515, Japan.
Yoshii Y; Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.; Kanagawa Cancer Center, Kanagawa 241-8515, Japan.
Doi Y; Faculty of Science, Toho University, Funabashi 274-8510, Japan.
Pokaż więcej
Źródło:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Dec 21; Vol. 17 (1). Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A new variant of the colistin resistance gene MCR-1 with co-resistance to β-lactam antibiotics reveals a potential novel antimicrobial peptide.
Autorzy:
Liang L; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Department of Immunology, School of Medicine, Sun Yat-Sen University, Shenzhen, China.; Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.
Zhong LL; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Department of Immunology, School of Medicine, Sun Yat-Sen University, Shenzhen, China.; Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.
Wang L; Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, Shanghai Tech University, Shanghai, China.
Zhou D; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Department of Immunology, School of Medicine, Sun Yat-Sen University, Shenzhen, China.; Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.
Li Y; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Department of Immunology, School of Medicine, Sun Yat-Sen University, Shenzhen, China.; Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.
Li J; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Department of Immunology, School of Medicine, Sun Yat-Sen University, Shenzhen, China.; Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.
Chen Y; School of Laboratory Medicine, Chengdu Medical College, Chengdu, China.
Liang W; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Department of Immunology, School of Medicine, Sun Yat-Sen University, Shenzhen, China.; Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.
Wei W; Center for Tuberculosis Control of Guangdong Province, Guangzhou, Guangdong, China.
Zhang C; Center for Tuberculosis Control of Guangdong Province, Guangzhou, Guangdong, China.
Zhao H; Laboratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Lyu L; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Department of Immunology, School of Medicine, Sun Yat-Sen University, Shenzhen, China.; Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.
Stoesser N; Modernising Medical Microbiology, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Doi Y; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.; Department of Microbiology, Fujita Health University School of Medicine, Aichi, Japan.
Bai F; Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, Shanghai Tech University, Shanghai, China.
Feng S; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Department of Immunology, School of Medicine, Sun Yat-Sen University, Shenzhen, China.; Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.
Tian GB; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Department of Immunology, School of Medicine, Sun Yat-Sen University, Shenzhen, China.; Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China.
Pokaż więcej
Źródło:
PLoS biology [PLoS Biol] 2023 Dec 13; Vol. 21 (12), pp. e3002433. Date of Electronic Publication: 2023 Dec 13 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Colistin*/pharmacology
Escherichia coli Proteins*/genetics
Escherichia coli Proteins*/metabolism
Humans ; Anti-Bacterial Agents/pharmacology ; beta Lactam Antibiotics ; Lipid A ; Antimicrobial Peptides ; Monobactams ; Plasmids ; Drug Resistance, Bacterial/genetics ; Microbial Sensitivity Tests
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical Features, Genome Epidemiology, and Antimicrobial Resistance Profiles of Aeromonas spp. Causing Human Infections: A Multicenter Prospective Cohort Study.
Autorzy:
Sakurai A; Department of Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan.; Department of Microbiology, Fujita Health University School of Medicine, Aichi, Japan.
Suzuki M; Department of Microbiology, Fujita Health University School of Medicine, Aichi, Japan.
Ohkushi D; Department of Infectious Diseases, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Harada S; Department of Infection Control and Prevention, University of Tokyo Hospital, Tokyo, Japan.
Hosokawa N; Department of Infectious Diseases, Kameda Medical Center, Chiba, Japan.
Ishikawa K; Department of Infectious Diseases, St Luke's International Hospital, Tokyo, Japan.
Sakurai T; Department of Infectious Diseases, NTT Medical Center, Tokyo, Japan.
Ishihara T; Innovative and Clinical Research Promotion Center, Gifu University Hospital, Gifu, Japan.
Sasazawa H; Department of Infectious Diseases, Kameda Medical Center, Chiba, Japan.; Department of Internal Medicine/Infectious Diseases, Omachi Municipal General Hospital, Nagano, Japan.
Yamamoto T; Department of Infectious Diseases, Kameda Medical Center, Chiba, Japan.
Takehana K; Clinical Laboratory, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Koyano S; Department of Infection Control and Prevention, University of Tokyo Hospital, Tokyo, Japan.
Doi Y; Department of Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan.; Department of Microbiology, Fujita Health University School of Medicine, Aichi, Japan.; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Nov 16; Vol. 10 (12), pp. ofad587. Date of Electronic Publication: 2023 Nov 16 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
Autorzy:
Tsuchihashi K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Ito M; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Arita S; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Kusaba H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Medical Oncology Organization, Hamanomachi Hospital, Fukuoka, Japan.
Kusano W; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Matsumura T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Kitazono T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Ueno S; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Taguchi R; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yoshihiro T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Doi Y; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Arimizu K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Ohmura H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Kajitani T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Nio K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Medical Oncology Organization, Hamanomachi Hospital, Fukuoka, Japan.
Nakano M; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Oshima K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Tamura S; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Medical Oncology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Shirakawa T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Shimokawa H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Department of Hematology and Oncology, Japan Community Health care Organization Kyushu Hospital, Fukuoka, Japan.
Uchino K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Hanamura F; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.; Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan.
Okumura Y; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Komoda M; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Isobe T; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, Higashi-ku, 812-8582, Japan.
Ariyama H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
Esaki T; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Hashimoto K; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Komune N; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Matsuo M; Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Matsumoto K; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Asai K; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.; Department of radiation therapy, Hamanomachi Hospital, Fukuoka, Japan.
Yoshitake T; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yamamoto H; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Oda Y; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Baba E; Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Fukuoka, Higashi-ku, 812-8582, Japan. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Oct 31; Vol. 23 (1), pp. 1046. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Head and Neck Neoplasms*/therapy
Rhabdomyosarcoma*/pathology
Adult ; Humans ; Middle Aged ; Japan ; Neoplasm Recurrence, Local/therapy ; Retrospective Studies ; Salvage Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tyrosine Kinase Inhibitor Profiling Using Multiple Forskolin-Responsive Reporter Cells.
Autorzy:
Kasahara Y; Department of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan.
Tamamura S; Japan Biological Informatics Consortium (JBiC), 2-45 Aomi, Koto-ku, Tokyo 135-8073, Japan.
Hiyama G; Translational Research Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
Takagi M; Translational Research Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
Nakamichi K; Department of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan.
Doi Y; Department of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan.
Semba K; Department of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan.; Translational Research Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
Watanabe S; Translational Research Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
Ishikawa K; Japan Biological Informatics Consortium (JBiC), 2-45 Aomi, Koto-ku, Tokyo 135-8073, Japan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 08; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 08.
Typ publikacji:
Journal Article
MeSH Terms:
Tyrosine Kinase Inhibitors*
Protein Kinase Inhibitors*/pharmacology
Humans ; Dasatinib/pharmacology ; Colforsin/pharmacology ; Imatinib Mesylate/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing
Autorzy:
Doi Y
Abu Lila AS
Matsumoto H
Okada T
Shimizu T
Ishida T
Pokaż więcej
Temat:
tumor microenvironment
metronomic chemotherapy
S-1
liposome
nanocarrier
EPR effect
Medicine (General)
R5-920
Źródło:
International Journal of Nanomedicine, Vol Volume 11, Pp 5573-5582 (2016)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/improvement-of-intratumor-microdistribution-of-pegylated-liposome-via--peer-reviewed-article-IJN; https://doaj.org/toc/1178-2013
Dostęp URL:
https://doaj.org/article/7f85a698ddd64c22b8655c532867535c  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 27538

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies